| • |
Edward J. Benz, Jr., M.D.
President, Dana Farber Cancer Institute |
 |
| • |
Karen Bernstein, Ph.D.
Co-Founder, Chairman & Editor-in-Chief, BioCentury |
|
| • |
Deborah
W. Brooks, M.B.A., M.S.
Co-Founder, Michael J. Fox Foundation
for Parkinson's Research |
|
| • |
Stephen Friend, M.D.,
Ph.D.
President, Co-Founder and
Director, Sage Bionetworks |
|
| • |
Rachel King, M.B.A.
Chief Executive Officer, GlycoMimetics |
|
| • |
Jonathan Leff, M.B.A.
Managing Director, Warburg Pincus |
|
| • |
Garry
Neil, M.D.
Corporate Vice President, Corporate Office
of Science and Technology, Johnson & Johnson |
|
| • |
Melanie Schnoll Begun
Managing Director of Philanthropic
Services, Morgan Stanley Smith Barney |
|
| • |
Mark Simon, M.B.A.
President, Williver Group LLC;
Advisor, Torreya Partners |
|
| • |
Josh Sommer
Executive Director, Chordoma Foundation |
|
| • |
Chris Varma, Ph.D.
Entrepreneur-in-Residence, Third Rock
Ventures |
|
| • |
Keith Yamamoto, Ph.D.
Professor of Cellular and Molecular Pharmacology
Executive Dean of the School of Medicine, University of California San Francisco |
|
